Tofranil
Tofranil
- In our pharmacy you can buy tofranil without a prescription, with delivery across the United Kingdom and discreet packaging; officially imipramine is prescription-only in major markets but some pharmacies and online suppliers may sell it without a prescription.
- Tofranil (imipramine) is used for major depressive disorder and childhood nocturnal enuresis; it is a tricyclic antidepressant that inhibits the reuptake of noradrenaline and serotonin, increasing their levels in the brain.
- Usual dosages: adults for depression typically start at 75 mg/day in divided doses, increasing to 150–200 mg/day as needed (max 300 mg/day in severe cases); for nocturnal enuresis initial bedtime doses are 10–25 mg (children 6–12), up to 50 mg (6–12 yrs) or 75 mg (>12 yrs); elderly and children require lower starting doses.
- Form of administration: oral tablets (10 mg, 25 mg, 50 mg) and capsules (75 mg, 100 mg, 125 mg, 150 mg) — no topical or injectable preparations.
- Onset time: peak plasma levels are reached in about 2–6 hours; however, antidepressant clinical effects usually take several weeks (commonly 2–4 weeks) to become apparent.
- Duration of action: imipramine has a relatively long half-life allowing once- or twice-daily dosing; therapeutic coverage is generally maintained over 24 hours with appropriate dosing.
- Alcohol warning: avoid alcohol while taking tofranil — alcohol increases sedation and the risk of side effects such as drowsiness and impaired coordination.
- The most common side effect is drowsiness (sleepiness); other frequent effects include dry mouth, constipation, dizziness, orthostatic hypotension, blurred vision, weight gain and sweating.
- Would you like to try tofranil without a prescription?
Tofranil
Basic Tofranil Information
- INN (International Nonproprietary Name): Imipramine
- Brand Names Available In United Kingdom: Tofranil and generic imipramine hydrochloride or imipramine pamoate
- ATC Code: N06AA02
- Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg (imipramine hydrochloride); capsules 75 mg–150 mg (imipramine pamoate)
- Manufacturers In United Kingdom: Novartis (originator) and multiple generic manufacturers (examples: Teva, Mylan, Sandoz)
- Registration Status In United Kingdom: Authorised via national licences; prescription only
- OTC / Rx Classification: Prescription Only (Rx)
Important Instructions And Daily Integration
Tofranil (imipramine) is a prescription-only medicine and requires a valid prescription from an NHS GP or a private prescriber.
Online pharmacies in the UK will ask for a scanned or electronic prescription before dispensing.
Check Boots, LloydsPharmacy, Superdrug or your NHS repeat prescription service for routine supplies.
Safety-first: do not mix imipramine with monoamine oxidase inhibitors (MAOIs) and avoid alcohol while taking it.
Report palpitations, fainting, seizures or other worrying symptoms immediately to a clinician or via emergency services.
The MHRA monitors safety and accepts Yellow Card reports for suspected adverse reactions.
Practical daily integration: start at a low dose and take imipramine at the same time each day for dose adherence.
Bedtime dosing is often used where the drug causes drowsiness, and dosette boxes or phone reminders help adherence.
Carry an up-to-date list of medicines and health conditions when visiting any pharmacy or clinician.
Store at 20–25°C, out of direct sunlight and away from children.
If you live in England you may pay the NHS prescription charge per item; prescriptions are free in Scotland, Wales and Northern Ireland.
Ask your GP or pharmacist about generic imipramine hydrochloride or pamoate to reduce cost where appropriate.
Everyday Use & Best Practices
Morning Vs Evening Dosing
- Many UK prescribers recommend taking imipramine at night if it causes drowsiness.
- Alternatively, split doses into morning and evening to reduce daytime sedation.
- Peak blood levels occur roughly 2–6 hours after dosing, reflecting the imipramine half-life.
- The long half-life supports once- or twice-daily regimens depending on tolerability and response.
- If treating sleeping difficulties, a bedtime dose often gives better sleep without daytime sedation.
Taking With Or Without Meals (UK Diet Habits)
If tablets cause stomach upset, take imipramine with food such as toast, cereal or a cooked breakfast.
Avoid very heavy alcohol-containing meals while taking imipramine as alcohol increases sedation.
Use a checklist when you speak to your GP or pharmacist: current medicines, heart disease, glaucoma, urinary problems and pregnancy status.
For dose adherence, use NHS repeat prescriptions, set phone reminders or a dosette box and keep a medication list for travel or work.
Discuss divided dosing with the prescriber if low mood and fatigue predominate rather than insomnia.
Keywords to note commonly used in guidance include imipramine dosing, Tofranil bedtime and imipramine half-life.
Safety Priorities
Who Should Avoid It (MHRA Warnings)
| Contraindications | Precautions |
|---|---|
| Known hypersensitivity to imipramine or other tricyclics | Significant cardiac disease |
| Recent myocardial infarction or serious heart rhythm disorders | Seizure disorders |
| Concurrent use with MAOIs | Glaucoma (especially narrow-angle) |
| — | Urinary retention or prostatic enlargement |
| — | Severe hepatic or renal impairment |
Before prescribing, screen patients with a checklist: ECG where cardiac risk exists, blood pressure, current medication list and seizure history.
The MHRA collects safety data and clinicians or patients should report adverse events via the Yellow Card scheme.
Activities To Limit (Driving, Work Safety)
Imipramine commonly causes drowsiness, dizziness and orthostatic hypotension; avoid driving until you know how it affects you.
Do not operate heavy machinery or carry out safety-critical work until tolerance is established.
Alcohol increases sedation and the risk of falls or impaired judgement; avoid or minimise alcohol intake while taking imipramine.
Shift workers and those in safety-critical roles should discuss alternative treatments with their GP before starting imipramine.
Dosage & Adjustments
General Regimen (NHS Guidance)
| Condition | Typical Starting Dose | Maximum |
|---|---|---|
| Major Depressive Disorder (Adult) | 75 mg/day in divided doses | 300 mg/day |
| MDD (Elderly/Adolescents) | 25–50 mg/day in divided doses | As tolerated |
| Nocturnal Enuresis (6–12 yrs) | 25 mg at bedtime | 50 mg/night |
| Nocturnal Enuresis (over 12 yrs) | 25–50 mg at bedtime | 75 mg/night |
Typical adult depression regimens start around 75 mg/day in divided doses with gradual titration.
Many sources list increases to 150–200 mg/day as tolerated and up to 300 mg/day in severe cases.
Special Cases (Elderly, Comorbidities)
Elderly patients should start low, often 10–25 mg/day, and titrate slowly because of orthostatic hypotension and anticholinergic effects.
Reduce dose or monitor closely in hepatic or renal impairment due to the risk of accumulation.
For people on multiple medicines, check for interactions such as QT-prolonging drugs, MAOIs and SSRIs before dose changes.
Consider baseline ECG before high-dose therapy in patients with cardiac risk factors and align changes with NHS prescriber guidance.
User Testimonials
Positive Reports From UK Patients
- Some patients report meaningful mood improvement when SSRIs were not well tolerated.
- People taking an evening dose often note better sleep and reduced night-time anxiety.
- Paediatric cases of nocturnal enuresis sometimes show helpful reduction in bedwetting under paediatric supervision.
- Many patients praise pharmacist counselling at Boots or LloydsPharmacy for clear side-effect explanations.
Common Challenges (Patient.info, NHS Forums)
- Dry mouth, constipation and daytime drowsiness are commonly described on forums and Patient.info.
- Weight gain and occasional blurred vision or sweating are reported by some patients.
- Difficulty with titration and tolerability leads some people to switch to SSRIs or SNRIs.
- Forum advice stresses close GP follow-up, baseline ECGs for older patients and gradual tapering to avoid withdrawal.
When discussing experiences with a GP, bring a checklist: benefits seen, side effects, sleep pattern changes and any new symptoms.
Buying Guide
Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)
Tofranil and generic imipramine are prescription-only in the UK and are supplied via NHS prescriptions or community pharmacies such as Boots, LloydsPharmacy and Superdrug.
MHRA‑regulated online pharmacies may dispense imipramine but will request a valid prescription before supply.
In our online pharmacy, tofranil is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
Always verify that any online supplier is registered with the General Pharmaceutical Council (GPhC) before ordering.
Price Comparison (NHS Prescription Charge Vs Private)
| Source | Prescription Required | Likely Cost | Notes |
|---|---|---|---|
| NHS Prescription | Yes | England: per-item charge; Scotland/Wales/NI: free | Generic options usually cheaper |
| Community Pharmacy (Boots/Lloyds/Superdrug) | Yes | Varies; usually align with NHS pricing | Pharmacist can suggest generics |
| Private Prescription/Online Pharmacy | Yes (private Rx) or online supply with Rx | Varies by supplier; ask for generic imipramine | Check GPhC registration and expiry box on receipt |
Ask your pharmacist about imipramine hydrochloride versus imipramine pamoate for cost and formulation differences.
What’s Inside & How It Works
Ingredients Overview
- Active Ingredient: imipramine (imipramine hydrochloride or imipramine pamoate).
- Forms Available In The EU: tablets 10 mg, 25 mg, 50 mg; capsules 75 mg–150 mg in some markets.
- Excipients vary by manufacturer; always check the patient information leaflet for allergens.
- There are no topical or injectable imipramine preparations in standard practice.
Mechanism Basics Explained Simply
Imipramine is a tricyclic antidepressant and is classified under ATC N06AA02 as a non-selective monoamine reuptake inhibitor.
It inhibits the reuptake of noradrenaline and serotonin, increasing their availability in the brain to help improve mood.
The same noradrenergic and serotonergic effects are also linked to its ability to reduce childhood nocturnal enuresis in selected cases.
Peak plasma levels occur about 2–6 hours after a dose and the long half-life supports once- or twice-daily dosing.
Imipramine is not considered habit-forming, but abrupt cessation can cause discontinuation symptoms and a supervised taper is recommended.
Main Indications
Approved Uses (MHRA Listing)
| Approved | Typical Use |
|---|---|
| Major Depressive Disorder | Used where other options are unsuitable or not tolerated |
| Childhood Nocturnal Enuresis | Short-term use under paediatric supervision (regulatory approvals vary) |
Off-Label Uses In UK Clinics
Imipramine is sometimes used off-label for treatment-resistant depression, certain chronic pain syndromes and neuropathic pain.
NICE typically recommends SSRIs as first-line for depression and reserves TCAs for patients who have not responded to or cannot tolerate first-line agents.
NHS clinicians weigh the benefits of imipramine against anticholinergic and cardiac risks before prescribing for off-label indications.
Interaction Warnings
Food Interactions (Alcohol, Tea/Coffee)
Avoid alcohol while taking imipramine as it increases sedation and can worsen cognitive impairment and orthostatic hypotension.
Caffeine from tea or coffee does not block antidepressant effects but may increase tremor or sleep disturbance in sensitive patients.
If anxiety or jitteriness increases after starting imipramine, consider moderating caffeine intake and discuss with your prescriber.
Drug Conflicts (MHRA Yellow Card Reports)
Do not co-prescribe imipramine with MAOIs because of the risk of hypertensive crisis and serotonin syndrome.
Exercise caution when combining imipramine with SSRIs, other TCAs, antipsychotics or drugs that prolong the QT interval.
Anticholinergic burden from antihistamines, bladder antispasmodics or some antipsychotics increases risk of dry mouth, constipation and confusion.
Lithium, beta-blockers and certain antiarrhythmics may require monitoring when used with imipramine.
Serious interactions or adverse events should be reported to the MHRA Yellow Card scheme by clinicians or patients.
Latest Evidence & Insights
Key UK & EU Studies 2022–2025
- Recent systematic reviews confirm tricyclics like imipramine are effective but have higher anticholinergic and cardiovascular risks than SSRIs.
- NICE guidance continues to favour SSRIs or SNRIs first-line for depression, reserving TCAs for later lines or specific indications.
- Evidence supports cautious use in treatment-resistant depression and selected paediatric enuresis cases with close monitoring.
Practical Takeaways For Prescribers
Reserve imipramine for patients who have not tolerated or not responded to first-line therapies and use the lowest effective dose.
Perform a baseline ECG for patients with cardiac risk and plan review within 1–2 weeks after starting or changing dose.
Review concurrent medicines for QT prolongation and anticholinergic burden and consider specialist referral for complex comorbidity.
Check NICE and MHRA updates regularly as ongoing trials and safety reviews may influence practice through 2025.
Alternative Choices
NHS Prescribing Alternatives With Pros/Cons Checklist
| Drug/Class | Pros | Cons |
|---|---|---|
| SSRIs (Fluoxetine, Sertraline, Citalopram) | Generally better tolerated; safer in overdose | Sexual side effects; delayed onset of effect |
| SNRIs (Venlafaxine, Duloxetine) | Useful with pain comorbidity | Withdrawal risk; blood pressure effects for some |
| Other TCAs (Amitriptyline, Nortriptyline) | May help neuropathic pain and enuresis | Anticholinergic effects; cardiac risks |
Use a simple decision matrix considering efficacy, side-effect profile, safety in overdose, work and driving implications and cost.
Shared decision-making between clinician and patient is essential when choosing an antidepressant.
Regulation Snapshot
MHRA Approval & NHS Prescribing Framework
Imipramine (Tofranil) is prescription-only and regulated by the MHRA in the UK under national licensing arrangements.
NHS prescribers follow MHRA and NICE guidance when choosing imipramine and pharmacists must verify prescriptions on dispensing.
Common formulations in the EU include 10 mg, 25 mg and 50 mg tablets of imipramine hydrochloride.
Reporting & Monitoring (Yellow Card, Post‑Marketing)
Encourage patients and clinicians to report suspected adverse reactions via the MHRA Yellow Card scheme.
For higher-risk patients, consider pre-treatment ECG, blood pressure monitoring and regular medication reviews.
Generic imipramine options are widely available and prescribers may specify brand if clinically required.
FAQ
Can I Get Imipramine On The NHS?
Yes, imipramine can be prescribed on the NHS if your GP deems it clinically appropriate.
In England prescriptions may incur a per-item charge, while Scotland, Wales and Northern Ireland have free prescriptions for eligible patients.
Is It Safe For Older Adults?
Use cautiously in older adults with a low starting dose (commonly 10–25 mg/day) and slow titration.
Monitor for orthostatic hypotension, anticholinergic effects and consider baseline ECG where cardiac risk exists.
What If I Miss A Dose?
Take the missed dose as soon as you remember unless it is near the time for the next dose.
Do not double up doses to make up for a missed one and contact your GP or pharmacist for individual advice.
Can I Stop Suddenly?
No: do not stop abruptly as withdrawal symptoms can occur; taper gradually under supervision of your prescriber.
If severe side effects or emergency signs occur (seizure, fainting, severe palpitations), seek urgent medical help.
Guidelines For Proper Use
UK Pharmacist Counselling Style
- Confirm indication, dose, timing and expected onset (several weeks for depression).
- Explain common side effects: dry mouth, constipation, drowsiness, blurred vision and weight changes.
- Highlight serious warning signs: palpitations, fainting, seizures and severe confusion.
- Advise on storage (20–25°C), avoiding alcohol and checking interactions with OTC and prescription medicines.
- Document counselling in pharmacy records and recommend GP follow-up within 1–2 weeks of starting or dose change.
NHS Patient Support Advice
Signpost patients to their GP, local mental health services or IAPT where appropriate and to the MHRA Yellow Card for side effects.
For cost or access concerns advise discussing generic options or prescription exemptions with the GP.
Provide a simple patient handout template covering dose times, what to expect, when to seek help and how to taper safely.
Delivery Across United Kingdom
| City | Region | Delivery time |
|---|---|---|
| London | England | 5-7 days |
| Birmingham | England | 5-7 days |
| Manchester | England | 5-7 days |
| Glasgow | Scotland | 5-7 days |
| Leeds | England | 5-7 days |
| Edinburgh | Scotland | 5-7 days |
| Liverpool | England | 5-7 days |
| Bristol | England | 5-7 days |
| Newcastle Upon Tyne | England | 5-9 days |
| Belfast | Northern Ireland | 5-9 days |
| Cardiff | Wales | 5-9 days |
| Nottingham | England | 5-9 days |
| Southampton | England | 5-9 days |
| Leicester | England | 5-9 days |
